Upgrade to SI Premium - Free Trial

After-Hours Stock Movers 08/14: (FATE) (EXTR) (SYF) (P) (OMER)

August 14, 2017 5:53 PM
Fate Therapeutics (NASDAQ: FATE) up 16.2%; reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles